Literature DB >> 8416730

Papillary cystic tumors of the pancreas. Assessment of their malignant potential.

K Nishihara1, M Nagoshi, M Tsuneyoshi, K Yamaguchi, I Hayashi.   

Abstract

BACKGROUND: Although the biologic characteristics of papillary cystic tumors (PCT) generally indicate a good prognosis, a malignant form has been reported.
METHODS: Twenty-two examples of PCT were examined to assess their malignant potential by histologic, flow cytometric, and immunohistochemical studies.
RESULTS: Three had hepatic, peritoneal, and/or lymph node metastases (metastasizing tumors [MT]); the other 19 PCT had no such metastatic features (nonmetastasizing tumors [NMT]). Venous invasion was detected in all three MT and two NMT. Compared with the 19 NMT, the MT had a higher nuclear grade and more prominent necrobiotic nests characterized by aggregates of cells with pyknotic nuclei and eosinophilic cytoplasm. In the flow cytometric analysis of cellular DNA content, one MT was aneuploid, and eight NMT were diploid. Immunohistochemically, there was no difference between the MT and NMT.
CONCLUSIONS: These results support the assumption that venous invasion, nuclear grade, and prominent necrobiotic nests are useful as histologic parameters to detect the malignant potential of PCT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416730     DOI: 10.1002/1097-0142(19930101)71:1<82::aid-cncr2820710114>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  53 in total

1.  Multifocal papillary-cystic neoplasm of the pancreas.

Authors:  Frank P Lloyd; Jennifer Kang
Journal:  J Natl Med Assoc       Date:  2003-12       Impact factor: 1.798

2.  Solid pseudopapillary neoplasm of the pancreas mimicking a pseudocyst of pancreas.

Authors:  Bharti M Jha; Pinal Shah; Anshul Agarwal
Journal:  Med J Armed Forces India       Date:  2012-11-03

3.  Solid pseudopapillary neoplasm of the pancreas: CT imaging features and radiologic-pathologic correlation.

Authors:  Gopinathan Anil; Junwei Zhang; Nawal Ebrahim Al Hamar; Min En Nga
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

4.  Solid cystic tumor of the pancreas in elderly men: report of a case.

Authors:  H Takahashi; K Hashimoto; H Hayakawa; M Kusakawa; K Okamura; A Kosaka; R Mizumoto; K Katsuta
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Double Hamoudi: A case report.

Authors:  Inna V Grishkan; Claude Beaty; Matthew Weiss; Christopher Wolfgang; Mouen A Khashab; Samuel A Giday; Frederic E Eckhauser
Journal:  Int J Surg Case Rep       Date:  2011-11-10

6.  Subcutaneous metastasis as the first manifestation of a solid-pseudopapillary tumor of the pancreas.

Authors:  F Arias de la Vega; M L Gómez Dorronsoro; F J Jiménez
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

7.  Solid pseudopapillary neoplasms of the pancreas: Case series with a review of the literature.

Authors:  Alper Uğuz; Ömer Vedat Ünalp; Göksever Akpınar; Can Avni Karaca; Nevin Oruç; Deniz Nart; Funda Yılmaz; Ahmet Aydın; Ahmet Çoker
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

Review 8.  Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of solid pseudopapillary tumor of the pancreas: a case report and literature review.

Authors:  Charitini Salla; Paschalis Chatzipantelis; Panagiotis Konstantinou; Ioannis Karoumpalis; Akrivi Pantazopoulou; Victoria Dappola
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

9.  Papillary cystic tumours of the pancreas: an analysis by nuclear morphometry.

Authors:  K Nishihara; M Tsuneyoshi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  A case of recurrent solid pseudopapillary tumor of the pancreas with involvement of the spleen and kidney.

Authors:  Sang Eun Park; Nam Sook Park; Jae Min Chun; Nam Whan Park; Young Joon Yang; Gak Won Yun; Hyo Jin Lee; Hwan Jung Yun; Deog Yeon Jo; Kyu Sang Song; Samyong Kim
Journal:  Cancer Res Treat       Date:  2006-04-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.